Alzhmerat

Alzhmerat
Product Description

Group of action: Agents affecting the nervous system

Active ingredient: Choline alfoscerate

Dosage form: Solution for injections

Pharmacotherapeutic group: Medications that affect the nervous system. Parasympathomimetics. Choline alfoscerat.

Indications: The acute period of severe traumatic brain injury with a predominantly stem level of damage (impaired consciousness, coma, focal hemispheric symptoms, symptoms of damage to the brain stem). Degenerative-involutionary brain psychoorganic syndromes or secondary consequences of cerebrovascular insufficiency, that is, primary and secondary mental disorders in the elderly, which are characterized by impaired memory, confusion, disorientation, reduced motivation and initiative, reduced ability to concentrate; changes in the emotional sphere and sphere of behavior: emotional instability, irritability, indifference to the environment; pseudomelancholy in the elderly.

Lekhim

  • UA
  • 2019
    On CPHI since
Specifications

Lekhim

  • UA
  • 2019
    On CPHI since

More Products from Lekhim (2)

  • Pancreazim 10000

    Product Pancreazim 10000

    Lekhim is a leader in enzyme preparations among Ukrainian pharmaceutical manufacturers. Our TOP Product Pancreazim 10000 is EU GMP certified and being supplied to EU countries.

    Active ingredient:  Pancreatin

    Dosage form:  Enterosoluble tablets

    Ph...
  • Nevrolek

    Product Nevrolek

    Group of action: Agents affecting the digestive system and metabolism
    Active ingredient: Comb drug

    Dosage form: Solution for injections

    Pharmacotherapeutic group: Vitamin B1 in combination with vitamin B6 and / or B12.

    Indications: Neurological disorders of variou...